statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

111 to Announce First Quarter 2024 Unaudited Financial Results on May 23, 2024 - Conference Call to Follow 111 to Announce First Quarter 2024 Unaudited Financial Results on May 23, 2024 - Conference...

111 to Announce First Quarter 2024 Unaudited Financial Results on May 23, 2024 - Conference Call to Follow

Q4 2023 111 Inc Earnings Call Transcript

111 (NASDAQ:YI  Get Free Report) released its quarterly earnings results on Thursday. The company reported ($0.34) EPS for the quarter, Zacks reports. The company had revenue of $578.69...

111 (NASDAQ:YI) Releases Quarterly  Earnings Results

111, Inc. Announces Fourth Quarter and Fiscal Year 2023 Financial Results 111, Inc. Announces Fourth Quarter and Fiscal Year 2023 Financial Results PR Newswire SHANGHAI, March 21, 2024 SHANGHAI...

111, Inc. Announces Fourth Quarter and Fiscal Year 2023 Financial Results

111 to Announce Fourth Quarter and Fiscal Year 2023 Unaudited Financial Results- Conference Call to Follow 111 to Announce Fourth Quarter and Fiscal Year 2023 Unaudited Financial Results- Conference...

111 to Announce Fourth Quarter and Fiscal Year 2023 Unaudited Financial Results- Conference Call to Follow

111, Inc. (NASDAQ:YI  Get Free Report) saw a large drop in short interest in January. As of January 31st, there was short interest totalling 18,300 shares, a drop of 14.5% from the January...

Short Interest in 111, Inc. (NASDAQ:YI) Drops By 14.5%

111, Inc. engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through the B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies. The B2B segment includes the sale of pharmaceutical products to pharmacy customers through 1 Drug Mall. The company was founded by Gang Yu and Jun Ling Liu in May 2013 and is headquartered in Shanghai, China.

111 Inc - ADR

Volume	41,827.00
52-Wk High	$3.36
52-Wk Low	$0.9701

Period	Estimated	Reported	Surprise	Result
Q2'23	--	-$0.09	--	N/A
Q1'23	--	-$0.05	--	N/A
Q4'22	--	-$0.19	--	N/A
Q3'22	--	-$0.16	--	N/A
Q2'22	--	-$0.17	--	N/A

YI 111 Inc - ADR

About

Feed

News

Earnings

Fundamentals